Latest Stories
BD (NYSE:BDX) Surprises With Q4 CY2025 Sales
Medical technology company Becton, Dickinson and Company (NYSE:BDX) reported Q4 CY2025 results beating Wall Street’s revenue expectations, with sales up 1.6% year on year to $5.25 billion. Its non-GAAP profit of $2.91 per share was 3.5% above analysts’ consensus estimates.
Edgewell Personal Care (NYSE:EPC) Reports Q4 CY2025 Revenue Estimates
Personal care company Edgewell Personal Care (NYSE:EPC) reported earnings in Q4 CY2025. Consolidated Net Sales (Inclusive of the Feminine Care Business) were $486.8 million, ahead of expectations. Its non-GAAP profit of $0.03 per share was significantly above analysts’ consensus estimates.Correction note:The previous version of this report estimated quarterly sales at $422.8 million. This version has been updated to reflect the Consolidated Net Sales (Inclusive of the Feminine Care Business) of $486.8 million.The data used in the report besides Revenue, non GAAP EPS and non GAAP EBITDA are GAAP (continuing operations and exclude Femcare).
5 Must-Read Analyst Questions From Kforce’s Q4 Earnings Call
Kforce’s fourth quarter was met with a significant negative market reaction, as investors responded to both a year-on-year revenue decline and a substantial miss on profit expectations. Management attributed the quarter’s results to a combination of persistent weakness in the technology services sector and a challenging labor market, but pointed to sequential growth in its technology business and positive momentum entering the new year. CEO Joseph Liberatore described the environment as one where “clients may increasingly pursue a flexible talent model as a means to complete critical projects in this uncertain macro landscape.” The company also absorbed restructuring costs to better align its workforce and cost base with current demand.
The 5 Most Interesting Analyst Questions From MGIC Investment’s Q4 Earnings Call
MGIC Investment’s fourth quarter saw a negative market response, as revenue came in below analyst expectations and margins compressed compared to the prior year. Management attributed the results to a combination of stagnant new insurance growth and persistent high operating expenses, despite stable credit performance in its insurance portfolio. CEO Timothy James Mattke cited the company’s “disciplined risk management and a thoughtful, measured approach to the market,” while also acknowledging that housing affordability challenges and elevated mortgage rates limited near-term growth opportunities. CFO Nathaniel Howe Colson noted that expense reductions and steady investment income partially offset these pressures.
Woodward’s Q4 Earnings Call: Our Top 5 Analyst Questions
Woodward delivered a fourth quarter that exceeded Wall Street’s expectations, with management crediting robust demand in both its aerospace and industrial segments as primary drivers. CEO Charles P. Blankenship emphasized that “commercial services activity was robust across narrow-body, wide-body, and regional platforms,” and highlighted operational improvements that enabled the company to capitalize on strong order flow. Management also pointed to margin expansion in both segments, attributing this to a combination of pricing, higher volumes, and favorable mix, especially in commercial aerospace services and industrial power generation.
5 Revealing Analyst Questions From Teradyne’s Q4 Earnings Call
Teradyne’s fourth quarter was marked by strong top-line growth and an 11% revenue beat versus Wall Street expectations, leading to a significant positive market reaction. Management attributed this performance to a surge in demand for semiconductor and robotics testing solutions, particularly driven by AI data center buildouts. CEO Gregory Smith highlighted that "AI demand drove more than 60% of our revenue" in the quarter, with the Semiconductor Test, Product Test, and Robotics groups all posting double-digit sequential growth. The company also cited ongoing market share gains in high-bandwidth memory (HBM) and compute testing, as well as successful integration of recent acquisitions, as key contributors.
5 Revealing Analyst Questions From Napco’s Q4 Earnings Call
Napco’s fourth quarter saw a positive market response, reflecting management’s focus on channel normalization and recurring revenue expansion. The company highlighted strong growth in both equipment and service revenue, with improved gross margins attributed to reduced discounting and disciplined pricing. CEO Richard Soloway credited the company’s ability to maintain high gross margins in recurring revenue streams, particularly through the StarLink platform, as a key driver. The addition of a new Chief Revenue Officer was also noted as a move to further strengthen sales and support continued momentum across product lines.
5 Revealing Analyst Questions From Capital Southwest’s Q4 Earnings Call
Capital Southwest’s fourth-quarter results were marked by healthy top-line growth and profits ahead of Wall Street expectations, with management attributing performance to strong recurring earnings across its portfolio and successful realization of gains from equity exits. CEO Michael Sarner emphasized the impact of robust deal flow in the lower middle market and disciplined capital deployment, noting, “Deal flow in the lower middle market remained healthy this quarter. We closed $244 million in total new commitments.” The company also highlighted its ability to maintain a low nonaccrual rate and strong dividend coverage, supported by a diversified, primarily first lien senior secured loan portfolio.
The 5 Most Interesting Analyst Questions From DaVita’s Q4 Earnings Call
DaVita’s fourth quarter results drew a positive market response, as the company outpaced Wall Street expectations on both revenue and non-GAAP profit. Management identified revenue per treatment growth and disciplined execution in its Integrated Kidney Care (IKC) segment as the main contributors to performance, despite a year-over-year decline in operating margin. CEO Javier Rodriguez highlighted the company’s progress in patient outcomes within IKC programs, citing better treatment adherence and reduced hospitalizations. The quarter also saw the impact of higher health benefit costs, which partially offset operational gains.
5 Insightful Analyst Questions From NXP Semiconductors’s Q4 Earnings Call
NXP Semiconductors’ fourth quarter saw year-over-year growth driven by improved demand across automotive and industrial end markets. Management attributed the quarter’s performance to a rebound in automotive revenue, particularly as inventory adjustment cycles wound down, and to broad-based strength in industrial and IoT segments. CEO Rafael Sotomayor noted, “Our auto business returned to growth year-over-year, and the guide we provided continues that trend.” However, management also acknowledged that persistent weakness in communications infrastructure and the impact of recent divestitures, such as the sale of the MEMS sensor business, weighed on sentiment.